Viropharma
Shire delivers record revenues
February 16, 2015Sales and Marketing ADHD, AbbVie, Shire, Viropharma, Vyvanse, intuniv, lialda
Shire has posted strong growth in its full-year results, showing that the company is faring well even after the collapse …
Shire spends $4.2 billion on ViroPharma purchase
November 11, 2013Sales and Marketing Cinryze, Firazyr, Shire, Viropharma
Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …
EMA grants first paediatric use marketing authorisation
September 9, 2011Sales and Marketing Buccolam, PUMA, Viropharma, paediatric trials, seizures
The first children’s medicine to hold a new paediatric use marketing authorisation (PUMA), making it available for children only, has …
FDA rejects Viropharma’s Cinryze manufacturing expansion
October 25, 2010Sales and Marketing Cinryze, FDA, FDA complete response letter, Viropharma, angioedema, pharmaceutical manufacturing
ViroPharma was dealt a blow late last week when the FDA turned down its application for additional manufacturing capacity for …
Pharma manufacturing news in brief
July 6, 2010Manufacturing and Production BMS, Borregaard Synthesis, Colorcon, JHP Pharma, Saltigo, Sanofi-Aventis, Synthetech, Viropharma, univar
New capital investments from Sanofi-Aventis, Bristol-Myers Squibb, Viropharma and Colorcon head up this round-up of developments in the pharmaceutical manufacturing …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
